Takehisa Iwama

USPTO Granted Patents = 22 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 16 (Patent Applications = 23)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 37(Granted Patents)

Location History:

Minamisaitama-gun, JP (2000)
Tokyo, JP (2016)
Funabashi, JP (2013 - 2023)

Company Filing History:

21 out of 1,235

Nissan Chemical Industries Limited

Nissan Chemical Corporation

patents

5. 1 out of 26

Institute of National Colleges of Technology, Japan

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11771645 - Transdermally absorbable base material containing lipid peptide compound (2023-10-03),

2. 11452688 - Transdermally absorbable base material containing lipid peptide compound (2022-09-27),

3. 11371013 - Culture medium composition and method of culturing cell or tissue using thereof (2022-06-28),

4. 10590380 - Culture medium composition and method of culturing cell or tissue using thereof (2020-03-17),

5. 10487308 - Culture medium composition (2019-11-26),

6. 10421055 - Dispersion and method for forming hydrogel (2019-09-24),

7. 10316292 - Material for undifferentiated state-maintaining culture (2019-06-11),

8. 10017805 - Enhancing ingredients for protein production from various cells (2018-07-10),

9. 10010490 - Cosmetic composition comprising cellulose fibers with small fiber diameter and comparatively small aspect ratio (2018-07-03),

10. 9664671 - Culture medium composition and method of culturing cell or tissue using thereof (2017-05-30),

11. 9566218 - Production method of cosmetic, preparation method of gel for cosmetics, and method of reducing use amount of polymer thickener blended in cosmetic raw materials (2017-02-14),

12. 9561255 - Cosmetic, external skin preparation, and medical instrument (2017-02-07),

13. 9480772 - Gel sheet containing lipid peptide gelator and polymeric compound (2016-11-01),

14. 9333158 - Spray base material including low-molecular gelator (2016-05-10),

15. 9289496 - Lipid dipeptide and gel (2016-03-22),

Title: The Innovations of Takehisa Iwama: A Pioneer in Transdermal Technologies

Introduction: Takehisa Iwama, an accomplished inventor based in Funabashi, Japan, has made significant contributions to the field of transdermal delivery systems. With an impressive portfolio of 22 patents, Iwama's work reflects his commitment to advancing pharmaceutical technologies that enhance patient care.

Latest Patents: Among his latest innovations is a transdermally absorbable base material containing a lipid peptide compound. This invention includes a lipid peptide compound, a surfactant, polyhydric alcohol, fatty acids, and water. The innovative formulation is designed for improved absorption through the skin, showcasing Iwama's dedication to developing effective and efficient medical products.

Career Highlights: Iwama's career has been marked by notable achievements in the pharmaceutical industry. He has played a pivotal role at several esteemed organizations, including Nissan Chemical Industries Limited and Kyushu University. His work in these institutions has significantly impacted the development of transdermal drug delivery systems.

Collaborations: Throughout his career, Iwama has collaborated with distinguished professionals, including Nobuhide Miyachi and Takayuki Imoto. These collaborations have enriched his research and fostered innovations that contribute to the advancement of medical technology.

Conclusion: Takehisa Iwama exemplifies the spirit of innovation in the field of transdermal delivery systems. With his extensive patent portfolio and collaborative efforts in the pharmaceutical industry, Iwama continues to pave the way for new advancements that enhance healthcare solutions globally. His work not only benefits patients but also inspires future generations of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.